These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21667970)

  • 41. Discovery of novel cathepsin S inhibitors by pharmacophore-based virtual high-throughput screening.
    Markt P; McGoohan C; Walker B; Kirchmair J; Feldmann C; De Martino G; Spitzer G; Distinto S; Schuster D; Wolber G; Laggner C; Langer T
    J Chem Inf Model; 2008 Aug; 48(8):1693-705. PubMed ID: 18637674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-based design of potent aromatase inhibitors by high-throughput docking.
    Caporuscio F; Rastelli G; Imbriano C; Del Rio A
    J Med Chem; 2011 Jun; 54(12):4006-17. PubMed ID: 21604760
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of structure- and ligand-based virtual screening protocols considering hit list complementarity and enrichment factors.
    Krüger DM; Evers A
    ChemMedChem; 2010 Jan; 5(1):148-58. PubMed ID: 19908272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery of a novel protein kinase B inhibitor by structure-based virtual screening.
    Medina-Franco JL; Giulianotti MA; Yu Y; Shen L; Yao L; Singh N
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4634-8. PubMed ID: 19604696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of novel Pim-1 kinase inhibitors by a hierarchical multistage virtual screening approach based on SVM model, pharmacophore, and molecular docking.
    Ren JX; Li LL; Zheng RL; Xie HZ; Cao ZX; Feng S; Pan YL; Chen X; Wei YQ; Yang SY
    J Chem Inf Model; 2011 Jun; 51(6):1364-75. PubMed ID: 21618971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery of small molecule inhibitors of integrin alphavbeta3 through structure-based virtual screening.
    Zhou Y; Peng H; Ji Q; Qi J; Zhu Z; Yang C
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5878-82. PubMed ID: 16982193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel pyridobenzimidazole derivatives exhibiting antifungal activity by the inhibition of beta-1,6-glucan synthesis.
    Takeshita H; Watanabe J; Kimura Y; Kawakami K; Takahashi H; Takemura M; Kitamura A; Someya K; Nakajima R
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3893-6. PubMed ID: 20605446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening.
    Miguet L; Zervosen A; Gerards T; Pasha FA; Luxen A; Distèche-Nguyen M; Thomas A
    J Med Chem; 2009 Oct; 52(19):5926-36. PubMed ID: 19746934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of novel selective antagonists for cyclin C by homology modeling and virtual screening.
    Rajender PS; Vasavi M; Vuruputuri U
    Int J Biol Macromol; 2011 Mar; 48(2):292-300. PubMed ID: 21138743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of new inhibitors of Schistosoma mansoni PNP by pharmacophore-based virtual screening.
    Postigo MP; Guido RV; Oliva G; Castilho MS; da R Pitta I; de Albuquerque JF; Andricopulo AD
    J Chem Inf Model; 2010 Sep; 50(9):1693-705. PubMed ID: 20695479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
    Evers A; Hessler G; Matter H; Klabunde T
    J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of potent inhibitors of soluble epoxide hydrolase by combinatorial library design and structure-based virtual screening.
    Xing L; McDonald JJ; Kolodziej SA; Kurumbail RG; Williams JM; Warren CJ; O'Neal JM; Skepner JE; Roberds SL
    J Med Chem; 2011 Mar; 54(5):1211-22. PubMed ID: 21302953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual binding mode of a novel series of DHODH inhibitors.
    Baumgartner R; Walloschek M; Kralik M; Gotschlich A; Tasler S; Mies J; Leban J
    J Med Chem; 2006 Feb; 49(4):1239-47. PubMed ID: 16480261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia.
    da Silva VB; Taft CA; Silva CH
    J Phys Chem A; 2008 Mar; 112(10):2007-11. PubMed ID: 18044855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improving VEGFR-2 docking-based screening by pharmacophore postfiltering and similarity search postprocessing.
    Planesas JM; Claramunt RM; Teixidó J; Borrell JI; Pérez-Nueno VI
    J Chem Inf Model; 2011 Apr; 51(4):777-87. PubMed ID: 21417262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Homology modeling, docking and molecular dynamics studies of some secondary metabolites of actinomycetes as biocontrol agents against the 3HNR enzyme of the phytopathogenic fungus
    Mansouri N; Benslama O; Arhab R
    J Biomol Struct Dyn; 2023 Feb; 41(3):871-883. PubMed ID: 34895071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of screening assays and discovery of initial inhibitors of pneumococcal peptidoglycan deacetylase PgdA.
    Bui NK; Turk S; Buckenmaier S; Stevenson-Jones F; Zeuch B; Gobec S; Vollmer W
    Biochem Pharmacol; 2011 Jul; 82(1):43-52. PubMed ID: 21501597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
    Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
    ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting wall techoic acid biosynthesis: an in vivo based high-throughput screen for small molecule inhibitors.
    Chen W; Woodward R; Wang PG
    ACS Chem Biol; 2009 Nov; 4(11):893-4. PubMed ID: 19888733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.